Join
Live feed
·
NEWSReleasevia Quantisnow
Halozyme Therapeutics Inc. logo

Halozyme's OCREVUS SC Gets European Approval for Multiple Sclerosis Treatment

ByQuantisnow·Wall Street's wire, on your screen.
HALO· Halozyme Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HALO (Halozyme Therapeutics Inc.) and more on Quantisnow.

Halozyme's OCREVUS SC Gets European Approval for Multiple Sclerosis Treatment | Quantisnow